Shares of Global Medical REIT Inc (NASDAQ:GMRE) have earned an average rating of “Buy” from the eight brokerages that are presently covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $10.67.

A number of brokerages have recently issued reports on GMRE. TheStreet raised Global Medical REIT from a “d” rating to a “c-” rating in a report on Monday, July 10th. Zacks Investment Research raised Global Medical REIT from a “hold” rating to a “buy” rating and set a $10.00 price target on the stock in a report on Wednesday, July 12th. FBR & Co reaffirmed an “outperform” rating and set a $10.00 price target on shares of Global Medical REIT in a report on Tuesday, July 11th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $12.00 price target on shares of Global Medical REIT in a report on Friday, September 1st. Finally, DA Davidson downgraded Global Medical REIT from a “buy” rating to a “neutral” rating and lowered their price target for the company from $11.00 to $10.00 in a report on Tuesday, August 22nd.

ILLEGAL ACTIVITY WARNING: “Global Medical REIT Inc (GMRE) Given Consensus Recommendation of “Buy” by Analysts” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another website, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/09/17/global-medical-reit-inc-gmre-given-consensus-recommendation-of-buy-by-analysts.html.

In other news, Chairman Jeffrey Busch acquired 11,100 shares of Global Medical REIT stock in a transaction that occurred on Friday, June 30th. The stock was bought at an average price of $9.00 per share, for a total transaction of $99,900.00. Following the completion of the transaction, the chairman now owns 20,110 shares in the company, valued at $180,990. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

A number of institutional investors have recently bought and sold shares of GMRE. UBS Group AG increased its position in Global Medical REIT by 14.2% during the first quarter. UBS Group AG now owns 11,847 shares of the company’s stock valued at $108,000 after acquiring an additional 1,477 shares during the last quarter. Spirit of America Management Corp NY increased its position in Global Medical REIT by 50.0% during the second quarter. Spirit of America Management Corp NY now owns 15,000 shares of the company’s stock valued at $134,000 after acquiring an additional 5,000 shares during the last quarter. Citadel Advisors LLC purchased a new stake in Global Medical REIT during the first quarter valued at $137,000. Wedbush Securities Inc. increased its position in Global Medical REIT by 5.8% during the second quarter. Wedbush Securities Inc. now owns 15,334 shares of the company’s stock valued at $137,000 after acquiring an additional 834 shares during the last quarter. Finally, Rhumbline Advisers increased its position in Global Medical REIT by 47.6% during the second quarter. Rhumbline Advisers now owns 17,699 shares of the company’s stock valued at $158,000 after acquiring an additional 5,710 shares during the last quarter.

Shares of Global Medical REIT (NASDAQ GMRE) traded down 1.60% during midday trading on Friday, hitting $9.21. The stock had a trading volume of 1,399,881 shares. The stock’s 50-day moving average is $9.31 and its 200-day moving average is $8.95. Global Medical REIT has a 12 month low of $6.73 and a 12 month high of $10.64.

Global Medical REIT (NASDAQ:GMRE) last announced its quarterly earnings results on Thursday, August 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.17). The business had revenue of $7.42 million for the quarter, compared to the consensus estimate of $6.16 million. Global Medical REIT had a negative net margin of 8.39% and a negative return on equity of 1.53%. Equities analysts expect that Global Medical REIT will post ($0.12) earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 9th. Investors of record on Tuesday, September 26th will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 8.69%. The ex-dividend date of this dividend is Monday, September 25th.

Global Medical REIT Company Profile

Analyst Recommendations for Global Medical REIT (NASDAQ:GMRE)

Receive News & Ratings for Global Medical REIT Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT Inc and related companies with MarketBeat.com's FREE daily email newsletter.